Back
Day Range
$8.22
$8.22
52-Week Range
$6.60
$14.80
Volume
100
50D / 200D Avg
$10.28
/
$11.44
Prev Close
$8.22
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 34.2 | 0.4 |
| P/B | 3.1 | 2.9 |
| ROE % | 8.7 | 3.7 |
| Net Margin % | 47.1 | 3.8 |
| Rev Growth 5Y % | 112.0 | 10.0 |
| D/E | 0.0 | 0.2 |
Key Takeaways
Revenue grew 112.02% annually over 5 years — strong growth
Earnings declined -78.58% over the past year
Net margin of 47.09% shows strong profitability
Debt/Equity of 0.00 — conservative balance sheet
Generating 125.34M in free cash flow
P/E of 34.22 — premium valuation
Growth
Revenue Growth (5Y)
112.02%
Revenue (1Y)-70.20%
Earnings (1Y)-78.58%
FCF Growth (3Y)-17.66%
Quality
Return on Equity
8.67%
ROIC4.88%
Net Margin47.09%
Op. Margin34.07%
Safety
Debt / Equity
0.00
Current Ratio76.60
Interest Coverage0.00
Valuation
P/E Ratio
34.22
P/B Ratio3.08
EV/EBITDA47.09
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -70.20% | Revenue Growth (3Y) | -47.22% |
| Earnings Growth (1Y) | -78.58% | Earnings Growth (3Y) | -55.99% |
| Revenue Growth (5Y) | 112.02% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 64.61M | Net Income (TTM) | 30.42M |
| ROE | 8.67% | ROA | 8.88% |
| Gross Margin | 99.96% | Operating Margin | 34.07% |
| Net Margin | 47.09% | Free Cash Flow (TTM) | 125.34M |
| ROIC | 4.88% | FCF Growth (3Y) | -17.66% |
| Safety | |||
| Debt / Equity | 0.00 | Current Ratio | 76.60 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | 34.22 | P/B Ratio | 3.08 |
| P/S Ratio | 16.11 | PEG Ratio | -1.05 |
| EV/EBITDA | 47.09 | Dividend Yield | 0.00% |
| Market Cap | 1.04B | Enterprise Value | 1.04B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 64.61M | 216.83M | 231.93M | 14.55M | 3.20M |
| Net Income | 30.42M | 142.04M | 157.08M | 184,000.0 | -7.79M |
| EPS (Diluted) | 0.24 | 1.09 | 1.20 | 0.00 | -0.07 |
| Gross Profit | 64.59M | 183.86M | 205.17M | 14.54M | 3.19M |
| Operating Income | 22.02M | 146.19M | 172.49M | -1.60M | -17.75M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 342.72M | 409.71M | 247.97M | 43.27M | 40.06M |
| Total Liabilities | 4.40M | 45.80M | 42.76M | 1.68M | 803,000.0 |
| Shareholders' Equity | 338.32M | 363.90M | 205.21M | 41.59M | 39.25M |
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 4.23M | 3.15M | 17.09M | 40.18M | 36.78M |
| Current Assets | 332.10M | 399.33M | 247.16M | 43.25M | 40.04M |
| Current Liabilities | 4.34M | 45.76M | 42.76M | 1.68M | 803,000.0 |